Search Results - "Bohan, Phillip M Kemp"

Predictors and benefits of multiagent chemotherapy for pancreatic adenocarcinoma: Timing matters by Valdera, Franklin A., O'Shea, Anne E., Smolinsky, Todd R., Carpenter, Elizabeth L., Adams, Alexandra A., McCarthy, Patrick M., Tiwari, Ankur, Chick, Robert C., Kemp‐Bohan, Phillip M., Van Decar, Spencer, Thomas, Katryna K., Bader, Julia O., Peoples, George E., Clifton, Guy T., Stojadinovic, Alex, Nelson, Daniel W., Vreeland, Timothy J.

“…Introduction Adjuvant (A) multiagent chemotherapy (MC) is the standard of care for patients with pancreatic adenocarcinoma (PDAC). Tolerating MC following a…”
Get full text

Examining Perioperative Risk Associated with Simultaneous Resection of Primary Neuroendocrine Tumors and Synchronous Hepatic Metastases by Heidenreich, Bethany M., Kemp Bohan, Phillip M., Flor, Remigio J., Bader, Julia O., Vreeland, Timothy J., O’Connor, Victoria V., Nelson, Daniel W.

“…Background Surgical debulking of primary neuroendocrine tumors (NETs) and hepatic resection of metastatic NET disease may each independently improve overall…”
Get full text

Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer by Kemp Bohan, Phillip M., O’Shea, Anne E., Ellis, Oriana V., Chick, Robert C., Clem, Alex M., Kirby, Derek T., Bader, Julia O., Newhook, Timothy E., Clifton, G. Travis, Tzeng, Ching-Wei D., Nelson, Daniel W., Vreeland, Timothy J.

“…Introduction Lymphadenectomy (LND) is recommended following surgical resection of ≥ T1b gallbladder cancer (GBC). However, frequency and stage-specific…”
Get full text

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement by Kemp Bohan, Phillip M., Chick, Robert C., Hickerson, Annelies T., Messersmith, Lynn M., Williams, Grant M., Cindass, Jessica L., Lombardo, Jamie, Collins, Ryan, Brady, Robert O., Hale, Diane F., Peoples, George E., Vreeland, Timothy J., Clifton, Guy T.

“…Background Colorectal cancer (CRC) tumor microenvironment (TME) characteristics, such as tumor infiltrating lymphocyte (TIL) densities and PD-L1 status, are…”
Get full text

Early analysis of laparoscopic common bile duct exploration simulation by Kemp Bohan, Phillip M., BA, Connelly, Christopher R., MD, Crawford, Jeff, MD, Bronson, Nathan W., MD, Schreiber, Martin A., MD, Lucius, Chris W., MD, Hunter, John G., MD, Kiraly, Laszlo N., MD, Ham, Bruce, MD

“…Abstract Background We developed a laparoscopic common bile duct exploration (LCBDE) simulation course for resident surgeons (RS) and practicing surgeons (PS)…”
Get full text

ASO Author Reflections: The Complexity of the Volume–Outcome Relationship in Pancreatic Cancer by Kemp Bohan, Phillip M., Nelson, Daniel W.

Get full text

A night float week in a surgical clerkship improves student team cohesion by Connelly, Christopher R., M.D, Kemp Bohan, Phillip M., B.A, Cook, Mackenzie R., M.D, Moren, Alexis M., M.D., M.P.H, Schreiber, Martin A., M.D, Kiraly, Laszlo N., M.D

“…Abstract Background We hypothesize that night float rotations in the third-year surgical clerkship improve student learning and perceptions of team cohesion…”
Get full text

The found down patient: A Western Trauma Association multicenter study by Howard, Benjamin M, Kornblith, Lucy Z, Conroy, Amanda S, Burlew, Clay Cothren, Wagenaar, Amy E, Chouliaras, Konstantinos, Hill, J Ryan, Carrick, Matthew M, Mallory, Gina R, Watkins, Jeffrey R, Truitt, Michael S, Ciesla, David J, Davis, Jaime A, Vail, Christopher J, Kemp Bohan, Phillip M, Nelson, Mary F, Callcut, Rachael A, Cohen, Mitchell Jay

“…Unconscious patients who present after being "found down" represent a unique triage challenge. These patients are selected for either trauma or medical…”
Get full text

Multi‐institutional, prospective, randomized, double‐blind, placebo‐controlled phase IIb trial of the tumor lysate, particle‐loaded, dendritic cell (TLPLDC) vaccine to prevent recurrence in high‐risk melanoma patients: A subgroup analysis by Chick, Robert C., Faries, Mark B., Hale, Diane F., Kemp Bohan, Phillip M, Hickerson, Annelies T., Vreeland, Timothy J., Myers, John W., Cindass, Jessica L., Brown, Tommy A., Hyngstrom, John, Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Shaheen, Montaser, Clifton, Guy T., Park, Hyohyun, Sloan, Amanda J., Wagner, Thomas, Peoples, George E.

“…Background Checkpoint inhibitors (CPI) in combination with cell‐based vaccines may produce synergistic antitumor immunity. The primary analysis of the…”
Get full text

Optimizing physician skill development for medical students: The Four-part assessment by Watson, Justin J.J., MD, Kemp Bohan, Phillip M., BA, Ramsey, Katrina, MPH, Yonge, John D., MD, Connelly, Christopher R., MD, Mullins, Richard J., MD, Watters, Jennifer M., MD, Schreiber, Martin A., MD, Kiraly, Laszlo N., MD

“…Abstract Background Medical student performance has been poorly correlated with residency performance and warrants further investigation. We propose a novel…”
Get full text

Impact of Mediating and Confounding Variables on the Volume–Outcome Association in the Treatment of Pancreatic Cancer by Kemp Bohan, Phillip M., Chang, Shu-Ching, Grunkemeier, Gary L., Spitzer, Holly V., Carpenter, Elizabeth L., Adams, Alexandra M., Vreeland, Timothy J., Nelson, Daniel W.

“…Background High-volume centers (HVC), academic centers (AC), and longer travel distances (TD) have been associated with improved outcomes for patients…”
Get full text

ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer by Kemp Bohan, Phillip M., Nelson, Daniel W., Vreeland, Timothy J.

Get full text

Safety and efficacy of low-titer O whole blood resuscitation in a civilian level I trauma center by Kemp Bohan, Phillip M., McCarthy, Patrick M., Wall, Morgan E., Adams, Alexandra M., Chick, Robert C., Forcum, Jason E., Radowsky, Jason S., How, Remealle A., Sams, Valerie G.

“…BACKGROUND Military experience has shown low-titer O whole blood (LTOWB) to be safe and beneficial in the resuscitation of hemorrhaging trauma patients…”
Get full text

ASO Author Reflection: Trends and Impact of Adjuvant Chemotherapy in Resected Gallbladder Cancer: Going Beyond Trial Data by Bohan, Phillip M. Kemp, Nelson, Daniel W.

Get full text

Immunologic and dose dependent effects of rapamycin and its evolving role in chemoprevention by O'Shea, Anne E., Valdera, Franklin A., Ensley, Daniel, Smolinsky, Todd R., Cindass, Jessica L., Kemp Bohan, Phillip M., Hickerson, Annelies T., Carpenter, Elizabeth L., McCarthy, Patrick M., Adams, Alexandra M., Vreeland, Timothy J., Clifton, Guy T., Peoples, George E.

“…Rapamycin inhibits the mechanistic (formally mammalian) target of rapamycin (mTOR), an evolutionarily conserved intracellular kinase that influences activation…”
Get full text

Inhalation Injury Severity Score on Admission Predicts Overall Survival in Burn Patients by Flinn, Ashley N, Kemp Bohan, Phillip M, Rauschendorfer, Catherine, Le, Tuan D, Rizzo, Julie A

“…Abstract Inhalation injury is diagnosed in up to one-third of burn patients and is associated with increased morbidity and mortality. There are multiple…”
Get full text

Adjuvant Chemotherapy in Resectable Gallbladder Cancer is Underutilized Despite Benefits in Node-Positive Patients by Kemp Bohan, Phillip M., Kirby, Derek T., Chick, Robert C., Bader, Julia O., Clifton, G. Travis, Vreeland, Timothy J., Nelson, Daniel W.

“…Background Adjuvant chemotherapy (AC) is recommended following surgical resection of gallbladder cancer regardless of stage. However, stage-specific benefits…”
Get full text

A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis by Vreeland, Timothy J., Clifton, Guy T., Hale, Diane F., Chick, Robert C., Hickerson, Annelies T., Cindass, Jessica L., Adams, Alexandra M., Bohan, Phillip M. Kemp, Andtbacka, Robert H. I., Berger, Adam C., Jakub, James W., Sussman, Jeffrey J., Terando, Alicia M., Wagner, Thomas, Peoples, George E., Faries, Mark B.

“…Background Melanoma therapy has changed dramatically over the last decade with improvements in immunotherapy, yet many patients do not respond to current…”
Get full text

Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma by Spitzer, Holly V., Kemp Bohan, Phillip M., Carpenter, Elizabeth L., Adams, Alexandra M., Chang, Shu-Ching, Grunkemeier, Gary, Vreeland, Timothy J., Tzeng, Ching-Wei D., Katz, Matthew H. G., Nelson, Daniel W.

“…Background Achieving optimal surgical outcomes in pancreatic adenocarcinoma requires a combination of both curative-intent resection to oncologic standards and…”
Get full text

Chemoprevention in familial adenomatous polyposis: past, present and future by Kemp Bohan, Phillip M., Mankaney, Gautam, Vreeland, Timothy J., Chick, Robert C., Hale, Diane F., Cindass, Jessica L., Hickerson, Annelies T., Ensley, Daniel C., Sohn, Vance, Clifton, G. Travis, Peoples, George E., Burke, Carol A.

“…Familial adenomatous polyposis (FAP) is a hereditary colorectal cancer syndrome characterized by colorectal adenomas and a near 100% lifetime risk of…”
Get full text